Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension
Peroxisome proliferator-activated receptor-alpha (PPAR-α) activation by fenofibrate reduces blood pressure and sodium retention during DOCA-salt hypertension. PPAR-α activation reduces the expression of inflammatory cytokines, such as interleukin-6 (IL-6). Fenofibrate also induces cytochrome P450...
Saved in:
| Main Authors: | Dexter L. Lee, Justin L. Wilson, Rong Duan, Tamaro Hudson, Ahmed El-Marakby |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2011/502631 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma
Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin
II Infused Mice
by: Justin L. Wilson, et al.
Published: (2012-01-01) -
Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
by: K. Hashizume, et al.
Published: (2008-01-01) -
Peroxisome Proliferator-Activated Receptors and Shock State
by: Emanuela Esposito, et al.
Published: (2006-01-01) -
Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
by: Dingzhi Wang, et al.
Published: (2008-01-01) -
Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
by: Laurent Dubuquoy, et al.
Published: (2009-01-01)